Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Gold miner Alba's shares surge on progress at north Wales project

(Sharecast News) - The share price of Alba Mineral Resources jumped by a tenth on Thursday ahead of the next phase of underground blasting at the main gold target at its Clogau-St David's Gold Mine in north Wales. The company said that, due to the availability of its principal blasting contractor, blasting at the main Llechfraith Target will start in late-July.

"The company continues to make the detailed preparations for the blasting programme in preparation for the scheduled start date, including implementing modifications in order to achieve greater penetration and faster progression through the blasting sequences," Alba said.

Processing of the remaining ore stockpile is ongoing, with around 4 kg of concentrate currently at, or in transit to, the refiner for refining.

Meanwhile, Alba announced that it will be producing a limited series of 18 carat pendants from gold extracted from Clogau-St David's. They will be offered at a set price rather than at auction, with Alba shareholders able to access the sale before they go on wider sale.

Shares were up 10.7% at 0.025p by 0900 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.